Conduit Financial Statements From 2010 to 2026

CDTTW Stock   0.01  0.00  0.000005%   
Conduit Pharmaceuticals' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Conduit Pharmaceuticals' valuation are provided below:
There are over one hundred six available fundamental signals for Conduit Pharmaceuticals, which can be analyzed over time and compared to other ratios. All traders should should validate Conduit Pharmaceuticals' prevailing fundamental trends against the trends from 2010 to 2026 to make sure the company is sustainable.

Conduit Pharmaceuticals Total Revenue

1.11 Billion

Check Conduit Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Conduit Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 567.2 K, Selling General Administrative of 14.5 M or Total Revenue of 1.1 B, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Conduit financial statements analysis is a perfect complement when working with Conduit Pharmaceuticals Valuation or Volatility modules.
  
Build AI portfolio with Conduit Stock
Check out the analysis of Conduit Pharmaceuticals Correlation against competitors.
For more information on how to buy Conduit Stock please use our How to Invest in Conduit Pharmaceuticals guide.

Conduit Pharmaceuticals Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets3.2 M4.8 M1.3 M
Slightly volatile
Short and Long Term Debt TotalM8.6 M1.8 M
Slightly volatile
Other Current Liabilities1.7 M2.3 M608.2 K
Slightly volatile
Total Current Liabilities13 M12.4 M2.6 M
Slightly volatile
Cash605.2 K637.1 K409 K
Slightly volatile
Non Current Assets Total1.8 M1.7 M456.8 K
Slightly volatile
Long Term Debt1.5 M2.3 M1.1 M
Slightly volatile
Cash And Short Term Investments605.2 K637.1 K409 K
Slightly volatile
Common Stock Shares OutstandingM2.4 M693.8 K
Slightly volatile
Liabilities And Stockholders Equity3.2 M4.8 M1.3 M
Slightly volatile
Non Current Liabilities Total209.5 K220.5 K3.4 M
Slightly volatile
Other Current Assets971.7 K1.9 M414.1 K
Slightly volatile
Total LiabilitiesM12.6 MM
Slightly volatile
Total Current Assets2.5 M3.1 M941 K
Slightly volatile
Short Term Debt8.9 M8.5 M1.6 M
Slightly volatile
Common Stock16.9 K16.1 K3.8 K
Slightly volatile
Short and Long Term Debt8.7 M8.3 M1.6 M
Slightly volatile
Intangible Assets506 M481.9 M107.4 M
Slightly volatile
Net Receivables391.2 K440.1 K480.4 K
Slightly volatile
Good Will814.9 M916.8 MB
Slightly volatile
Short Term Investments295.8 M332.8 M363.2 M
Slightly volatile
Inventory274.5 M308.8 M337 M
Slightly volatile

Conduit Pharmaceuticals Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization567.2 K411.3 K537.6 K
Pretty Stable
Selling General Administrative14.5 M13.8 M4.9 M
Slightly volatile
Other Operating Expenses18.6 M17.7 M5.8 M
Slightly volatile
Research Development4.1 M3.9 M878.7 K
Slightly volatile
Total Operating Expenses18.1 M17.2 M5.7 M
Slightly volatile
Cost Of Revenue365.6 K411.3 K448.9 K
Slightly volatile

Conduit Pharmaceuticals Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Net Borrowings1.8 M2.8 M1.1 M
Slightly volatile
Begin Period Cash Flow5.1 M4.9 MM
Slightly volatile
Total Cash From Financing Activities5.9 MM3.2 M
Slightly volatile
End Period Cash Flow605.2 K637.1 K409 K
Slightly volatile
Change To Inventory19.5 M21.9 M23.9 M
Slightly volatile
Dividends Paid6.6 M7.4 M8.1 M
Slightly volatile
Change To Account Receivables15.1 M17 M18.5 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Capex To Depreciation0.0880.10.1095
Slightly volatile
Payables Turnover0.260.290.3147
Slightly volatile
Cash Per Share0.30.3159.8372
Slightly volatile
Days Payables Outstanding912K1.1 K
Slightly volatile
Income Quality0.470.491.3803
Pretty Stable
Intangibles To Total Assets274309337
Slightly volatile
Current Ratio0.280.290.8048
Pretty Stable
Capex Per Share0.02010.02260.0246
Slightly volatile
Interest Debt Per Share4.815.07218
Slightly volatile
Debt To Assets1.681.60.9
Slightly volatile
Days Of Payables Outstanding912K1.1 K
Slightly volatile
Quick Ratio0.280.290.8048
Pretty Stable
Cash Ratio0.05630.05930.4641
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio0.810.90.9876
Slightly volatile
Debt Ratio1.681.60.9
Slightly volatile

Conduit Fundamental Market Drivers

About Conduit Pharmaceuticals Financial Statements

Conduit Pharmaceuticals investors use historical fundamental indicators, such as Conduit Pharmaceuticals' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Conduit Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Revenue1.1 B1.1 B
Cost Of Revenue411.3 K365.6 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Conduit Stock Analysis

When running Conduit Pharmaceuticals' price analysis, check to measure Conduit Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Conduit Pharmaceuticals is operating at the current time. Most of Conduit Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Conduit Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Conduit Pharmaceuticals' price. Additionally, you may evaluate how the addition of Conduit Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.